Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M

techcrunch.com/2025/05/19/pharma-giant-regeneron-to-buy-23andme-and-its-customers-data-for-256m

Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction.
Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. The…

This story appeared on techcrunch.com, 2025-05-19 15:56:54.815000.
The Entire Business World on a Single Page. Free to Use →